|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/47 | |
| A61K 31/4704 | |||
| A61K 31/5355 | |||
| A61K 31/573 | |||
| A61P 37/00 |
| (11) | Number of the document | 2542078 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11751295.4 |
| Date of filing the European patent application | 2011-03-02 | |
| (97) | Date of publication of the European application | 2013-01-09 |
| (45) | Date of publication and mention of the grant of the patent | 2015-10-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/026879 |
| Date | 2011-03-02 |
| (87) | Number | WO 2011/109526 |
| Date | 2011-09-09 |
| (30) | Number | Date | Country code |
| 339363 P | 2010-03-03 | US |
| (72) |
HAVIV, Asi, IL
TARCIC, Nora, IL
|
| (73) |
Teva Pharmaceutical Industries Ltd.,
5 Basel Street P.O. Box 3190, 49131 Petach-Tikva,
IL
|
| (54) | TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD |
| TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD |